{
  "pdfPath": "/home/arkantu/Documentos/Zotero Biblioteca/Genetica/Herencia atípica - Mosaicismo UPD/Mosaic brain/Myers et al_2018_Parental Mosaicism in “De Novo” Epileptic Encephalopathies.pdf",
  "fileName": "Myers et al_2018_Parental Mosaicism in “De Novo” Epileptic Encephalopathies.pdf",
  "relativePath": "Genetica/Herencia atípica - Mosaicismo UPD/Mosaic brain/Myers et al_2018_Parental Mosaicism in “De Novo” Epileptic Encephalopathies.pdf",
  "text": "T h e n e w e ng l a n d j o u r na l o f m e dic i n e\n\n\n\n\n                                            C or r e sp ondence\n\n\n\n\n          Parental Mosaicism in “De Novo” Epileptic Encephalopathies\n        To the Editor: De novo disease-causing variants              this letter at NEJM.org) in each parent; this cover-\n        have been increasingly recognized in apparently              age threshold provided 86.6% power to detect a\n        sporadic, severe neurologic disorders in children,           1% minor allele frequency (as calculated with\n        including developmental and epileptic encepha-               the use of the binomial test). The variant was\n        lopathies1 and autism.2 Geneticists indicate that            validated in each proband; paternity and mater-\n        the risk of recurrence of these disorders in fami-           nity were genetically confirmed. Although ascer-\n        lies with one affected child is approximately 1%;            tainment bias is possible, particularly in families\n        this accounts for the fact that one parent may               with two affected children, genetic testing was\n        have gonadal mosaicism.2 In families with an                 commenced before the second affected child\n        affected child, the actual risk of recurrence may            was born or before the child became clinically\n        be as high as 50%.                                           affected by the disorder. Three probands showed\n            Using single-molecule molecular inversion                somatic mosaicism and so were excluded from\n        probes,3 we investigated the frequency of low-               the analysis.\n        level parental mosaicism in somatic tissue ob-                  We tested somatic tissue (blood or saliva)\n        tained from parents and their affected children              obtained from the parents in the remaining\n        with an apparently de novo pathogenic variant                120 families to infer gonadal mosaicism; of these,\n        (according to American College of Medical Ge-                10 parents (8.3%; 95% confidence interval, 3.4 to\n        netics and Genomics criteria4) in 1 of 33 genes              13.3) had mosaicism for their child’s pathogenic\n        known to cause developmental and epileptic en-               variant (6 fathers and 4 mothers; minor allele\n        cephalopathies. Of 154 consecutively ascertained             frequency, 1.4 to 30.6%; mean, 12.9%; median,\n        family trios (consisting of a child and his or her           9.4%) (Table 1). The minor allele frequency was\n        biologic parents), 123 (79.9%) yielded a minimum             well below that traditionally detected by means of\n        of 200 discrete captures (i.e., molecules) (see the          Sanger sequencing in 8 of these 10 parents. In the\n        Supplementary Methods section in the Supple-                 saliva and blood samples obtained from 8 of\n        mentary Appendix, available with the full text of            the 10 parents with mosaicism (Table 1), the mu-\n                                                                     tant allele had a similar frequency. Pathogenic\n                                                                     variants occurred in eight genes. These genes\n                 this week’s letters\n                                                                     included SCN1A in 3 of 40 families with appar-\n1646 Parental Mosaicism in “De Novo” Epileptic                       ently de novo SCN1A mutations; these findings\n     Encephalopathies                                                showing that approximately 10% of children with\n                                                                     an apparently de novo SCN1A variant had a parent\n1648 Prazosin for Post-Traumatic Stress Disorder                     with mosaicism replicated those of another study.5\n                                                                     In addition, one variant occurred in each of the\n1650 Noninvasive Ablation of Ventricular Tachycardia\n                                                                     following genes: SCN8A, GNB1, SLC6A1, DNM1,\n1652 Magnetic Resonance Imaging and Cardiac Devices                  KCNT1, CACNA1A, and KCNQ2. Owing to the small\n                                                                     sample size, we were unable to determine whether\n1653 Metastatic Prostate Cancer                                      certain genes, such as those encoding ion chan-\n1654 Kidney Diseases Associated with HIV Infection                   nels, were more prone to mosaicism.\n                                                                        In 13 of 120 families, a second child had\n1656 More on Adjuvant Therapy in Resected Melanoma                   seizures or a neurodevelopmental abnormality.\n                                                                     In 5 of these 13 families, the affected sibling\n\n\n                                             n engl j med 378;17   nejm.org   April 26, 2018\n\n                                         The New England Journal of Medicine\n            Downloaded from nejm.org on April 25, 2018. For personal use only. No other uses without permission.\n                          Copyright © 2018 Massachusetts Medical Society. All rights reserved.\n\f                                                                                                                               Table 1. Parental Mosaicism in 8.3% of Parents Who Had a Child with a Diagnosis of an Apparently De Novo Monogenic Developmental and Epileptic Encephalopathy.*\n\n                                                                                                                                                                                                                                                                               No. of\n                                                                                                                               Family                                                                     Parent with         Sample Type,         Phenotype of Parent        Affected     Phenotype of Affected Sibling,\n                                                                                                                                No.               Proband Phenotype                  Mutation             Mosaicism           % Mosaicism            with Mosaicism           Siblings           Mutation Status\n                                                                                                                              1                    Dravet syndrome                   SCN1A                   Father            Blood, 29.6;             Unaffected                0                       NA\n                                                                                                                                                                                     p.R101W                                   saliva, 16.7\n                                                                                                                              2                    Dravet syndrome                    SCN1A                 Mother             Blood, 17.6            Febrile seizure             0                       NA\n                                                                                                                                                                                     p.S1516*\n                                                                                                                              3                    Dravet syndrome                    SCN1A                  Father            Blood, 30.6;           Febrile seizure             1        Dravet syndrome, SCN1A\n                                                                                                                                                                                  p.I1483Mfs*18                                saliva, 24.1                                                   ­heterozygote\n                                                                                                                              4             Developmental and epileptic               SCN8A                  Father            Blood, 12.0;        Febrile seizures plus†         1        Febrile seizures plus,† focal\n                                                                                                                                               encephalopathy                        p.L1331V                                   saliva, 4.7                                                   ­seizures, learning difficul­\n                                                                                                                                                                                                                                                                                               ties, SCN8A heterozygote\n                                                                                                                              5             Developmental and epileptic              KCNT1                   Father            Blood, 10.8;       Mild autosomal dom­             0                       NA\n                                                                                                                                               encephalopathy                        p.R950Q                                   saliva, 14.0          inant nocturnal\n                                                                                                                                                                                                                                                     frontal lobe epilepsy\n\n\n\n\n                                                                                                       n engl j med 378;17\n                                                                                                                              6             Developmental and epileptic              KCNQ2                  Mother             Blood, 1.4;              Unaffected                0                       NA\n                                                                                                                                               encephalopathy                        p.V567D                                   saliva, 1.5\n                                                                                                                              7             Epilepsy with myoclonic–­                 SLC6A1                Mother             Blood, 8.0;              Unaffected                0                       NA\n\n\n\n\n                                                                                                       nejm.org\n                                                                                                                                                atonic seizures                       p.A334P                                  saliva, 9.3\n                                                                                                                                                                                                                                                                                                                              Correspondence\n\n\n\n\n                                                                                                                              8             Developmental and epileptic                GNB1                  Father             Blood, 7.8              Unaffected                0                       NA\n                                                                                                                                               encephalopathy                         p.A326T\n                                                                                                                              9             Developmental and epileptic             CACNA1A                 Mother             Blood, 6.4;              Unaffected                1        Developmental and epileptic\n                                                                                                                                               encephalopathy                        p.A713T                                   saliva, 8.5                                                    encephalopathy, CACNA1A\n\n\n\n\n                                                                                                       April 26, 2018\n\n                             The New England Journal of Medicine\n                                                                                                                                                                                                                                                                                              heterozygote\n                                                                                                                              10            Developmental and epileptic               DNM1                   Father            Blood, 4.5;              Unaffected                1        Developmental and epileptic\n                                                                                                                                               encephalopathy                        p.R237W                                   saliva, 4.1                                                    encephalopathy, DNM1\n                                                                                                                                                                                                                                                                                              ­heterozygote\n                                                                                                                              11            Developmental and epileptic              SYNGAP1                Inferred               ND                   Unaffected                1        Developmental and epileptic\n\n\n\n\n              Copyright © 2018 Massachusetts Medical Society. All rights reserved.\n                                                                                                                                               encephalopathy                       p.L150Vfs*6                                                                                               encephalopathy, SYNGAP1\n                                                                                                                                                                                                                                                                                              heterozygote\n                                                                                                                              12            Epilepsy with myoclonic–­                KIAA2022               Inferred               ND                   Unaffected                1        Epilepsy with myoclonic or\n                                                                                                                                                atonic seizures                       p.R322*                                                                                                  atonic seizures, KIAA2022\n                                                                                                                                                                                                                                                                                               heterozygote\n\n\n\n\nDownloaded from nejm.org on April 25, 2018. For personal use only. No other uses without permission.\n                                                                                                                             *\t\u0007NA denotes not applicable, and ND not detected..\n                                                                                                                             †\t\u0007Febrile seizures plus are febrile seizures that occur after the age when these seizures usually occur (3 months to 6 years) or when there are concurrent afebrile tonic–clonic seizures.\n\f                              T h e n e w e ng l a n d j o u r na l o f m e dic i n e\n\n\n\nhad a phenotype concordant with that of the                  Chontelle King, B.Sc.\nproband and shared the proband’s mutation.                   University of Otago\n                                                             Wellington, New Zealand\nHowever, parental mosaicism was detected in\nonly 3 of these 5 families (these 3 families were            Amy Lacroix, B.Sc.\ncaptured in the 10 in which we observed paren-               Michele G. Mehaffey, M.S.\ntal mosaicism). Mosaicism in a parent of the                 University of Washington\n                                                             Seattle, WA\nother 2 families may have been below the level\nof detection by means of single-molecule mo-                 Samuel F. Berkovic, M.D.\nlecular inversion probes or confined to gonadal              University of Melbourne\n                                                             Melbourne, VIC, Australia\ntissue (which we did not test). If so, we have\nunderestimated the true frequency of mosaicism               Gemma L. Carvill, Ph.D.\nin the parents. Conversely, only 1 of 8 siblings             Northwestern University Feinberg School of Medicine\n                                                             Chicago, IL\nwith a milder (discordant) phenotype carried\ntheir sibling’s mutation; mosaicism was detected             Lynette G. Sadleir, M.B., Ch.B., M.D.\nin their father. Targeted high-coverage testing of           University of Otago\n                                                             Wellington, New Zealand\nparents who have a child with a developmental\nand epileptic encephalopathy due to an appar-                Ingrid E. Scheffer, M.B., B.S., Ph.D.\nently de novo mutation may be helpful in coun-               University of Melbourne\n                                                             Melbourne, VIC, Australia\nseling parents regarding the risk of recurrence.\n    A parental history of seizures was associated            Heather C. Mefford, M.D., Ph.D.\nwith an increased likelihood of parental mosa-               University of Washington\n                                                             Seattle, WA\nicism (P = 0.03 by Fisher’s exact test). Of the 16\n                                                             hmefford@uw.edu\nparents who had a history of seizures, 4 had\n                                                                Drs. Scheffer and Mefford contributed equally to this letter.\nmosaicism and 12 did not; however, only 6 of                    Supported by grants from the National Institute of Neuro-\n104 families with unaffected parents carried a               logical Disorders and Stroke (R01 NS069605, to Dr. Mefford),\nvariant that was also present, in a mosaic pat-              the National Health and Medical Research Council of Australia\n                                                             (to Drs. Berkovic and Scheffer), and the Health Research Council\ntern, in either the mother or father (Table 1, and           of New Zealand and Cure Kids New Zealand (to Drs. Sadleir and\nFig. S1 in the Supplementary Appendix). The level            Scheffer), and by postdoctoral fellowships from the Lennox–\nof mosaicism correlated broadly with the sever-              Gastaut Syndrome Foundation and the American Epilepsy So-\n                                                             ciety (to Dr. Myers) and from the Dravet Syndrome Foundation\nity of disease in the 4 affected parents who were            (to Dr. Muir).\nfound to have mosaicism.                                        Disclosure forms provided by the authors are available with\n                                                             the full text of this letter at NEJM.org.\nCandace T. Myers, Ph.D.\nUniversity of Washington                                     1. Epi4K Consortium, Epilepsy Phenome/Genome Project. De\nSeattle, WA                                                  novo mutations in epileptic encephalopathies. Nature 2013;​501:​\n                                                             217-21.\nGeorgina Hollingsworth, M.G.C.\n                                                             2. Veltman JA, Brunner HG. De novo mutations in human ge-\nUniversity of Melbourne                                      netic disease. Nat Rev Genet 2012;​13:​565-75.\nMelbourne, VIC, Australia                                    3. Hiatt JB, Pritchard CC, Salipante SJ, O’Roak BJ, Shendure J.\n                                                             Single molecule molecular inversion probes for targeted, high-\nAlison M. Muir, Ph.D.                                        accuracy detection of low-frequency variation. Genome Res 2013;​\nUniversity of Washington                                     23:​843-54.\nSeattle, WA                                                  4. Richards S, Aziz N, Bale S, et al. Standards and guidelines\n                                                             for the interpretation of sequence variants: a joint consensus\nAmy L. Schneider, M.G.C.                                     recommendation of the American College of Medical Genetics\nUniversity of Melbourne                                      and Genomics and the Association for Molecular Pathology.\nMelbourne, VIC, Australia                                    Genet Med 2015;​17:​405-24.\n                                                             5. Xu X, Yang X, Wu Q, et al. Amplicon resequencing identified\nZoe Thuesmunn                                                parental mosaicism for approximately 10% of “de novo” SCN1A\nAllison Knupp, M.S.                                          mutations in children with Dravet syndrome. Hum Mutat 2015;​\nUniversity of Washington                                     36:​861-72.\nSeattle, WA                                                  DOI: 10.1056/NEJMc1714579\n\n\n\n\n                                     n engl j med 378;17   nejm.org   April 26, 2018\n\n                                 The New England Journal of Medicine\n    Downloaded from nejm.org on April 25, 2018. For personal use only. No other uses without permission.\n                  Copyright © 2018 Massachusetts Medical Society. All rights reserved.",
  "wordCount": 1623,
  "indexed": "2025-09-25T22:41:14.380Z",
  "method": "direct"
}
